Skip to content
Use caution Medical device recall · FDA · Published May 28, 2026

SeaSpine Polyaxial Head Recall: Risk of Intraoperative Pop-Off

SeaSpine recalls polyaxial heads with REF 41-3010 due to potential pop-off during surgery. Affected lots include AW199682G and AW199684G. Contact for replacement.

🇺🇸 FDA recall #Z-2762-2026Medical deviceSeaSpine ›
✎ GovInfoNow plain-language explainer

What happened, in plain English

SeaSpine is recalling a specific type of surgical head that could detach during surgery due to a manufacturing error. This poses a risk of complications for patients undergoing procedures. Read more at govinfonow.com/recall/127866-seaspine-polyaxial-head-recall-risk-of-intraoperative-pop-off.

Source Summary by GovInfoNow · govinfonow.com/recall/127866-seaspine-polyaxial-head-recall-risk-of-intraoperative-pop-off · Updated August 10, 2026 · FDA enforcement record: FDA #Z-2762-2026

Cite this page

“SeaSpine Polyaxial Head Recall: Risk of Intraoperative Pop-Off.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/127866-seaspine-polyaxial-head-recall-risk-of-intraoperative-pop-off. Based on FDA recall #Z-2762-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2762-2026%22&limit=1).

Why it’s dangerous

The polyaxial head may detach from the screw during surgery due to a manufacturing error. This could lead to complications for patients if the head becomes dislodged during the procedure.

Who’s affected

Surgical teams using SeaSpine Polyaxial Heads with REF Number 41-301: 41-3010 are affected. Patients undergoing surgery with these devices are at risk of complications.

How to tell if you have this one

Check for the REF Number 41-3010 on the product. Affected lots are AW199682G and AW199684G. The device has a unique identifier (UDI) starting with 10889981155117.

  • Brand
    SeaSpine
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the REF Number and affected lots (AW199682G or AW199684G) on the device.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 25 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: named in the noticeMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: named in the noticeMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: nationwideIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: named in the noticeKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: nationwideNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: nationwideGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide - US Nationwide distribution including in the states of Alabama, Arizona, California, Colorado, Connecticut, Florida, Illinois, Indiana, Kansas, Maryland, Michigan, Missouri, Mississippi, Montana, Nevada, Ohio, Oklahoma, South…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, California, Colorado, Connecticut, Florida, Illinois, Indiana, Kansas, Maryland, Michigan, Mississippi, Missouri, Montana, Nevada, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, Wyoming.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: May 28, 202612. FDA classified it Class II: Jul 20, 202623. Published in FDA’s Enforcement Report: Jul 29, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have the recalled device?

Contact SeaSpine directly to confirm if your device is affected and get instructions for replacement.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2762-2026 (May 28, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2762-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA